Physician

Micheal Patrick Macken, MD

According to 2025 Medicare claims, Micheal Macken, MD (NPI: 1336110550) practices neuropsychiatry in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60611-2908. Macken is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620) and Northwestern Medicine Health Network ACO LLC (ACO ID: A5444), participating under the MSSP model.

Macken's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 503 traditional Medicare patients, billed 1,134 HCPCS/CPT codes, and received $88,116 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 2,442 prescription claims across 289 beneficiaries totaling $1,658,764 in drug costs, led by Briviact (Brivaracetam). Open Payments data shows 187 records totaling $117,199. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $356,222 to $1,658,764. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	342	692	$82,527
2016	319	632	$72,513
2017	388	838	$104,008
2018	419	1,096	$103,219
2019	417	945	$103,453
2020	407	953	$85,288
2021	387	814	$76,243
2022	497	806	$71,423
2023	544	941	$80,350
2024	503	1,134	$88,116

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	89	975	$356,222
2016	96	1,035	$441,107
2017	107	1,173	$491,953
2018	126	1,261	$589,028
2019	166	1,550	$875,166
2020	188	1,817	$1,135,115
2021	223	1,970	$1,432,124
2022	241	2,103	$1,825,806
2023	251	2,018	$1,626,804
2024	289	2,442	$1,658,764

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	91	198	$174
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	105	146	$89
95819	Measurement of brain wave activity (eeg), awake and asleep	120	120	$46
95938	Placement of skin electrodes and measurement of stimulated sites on arms and legs	90	91	$37
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	134	187	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Briviact	Brivaracetam	166	7,839	$425,593
Xcopri	Cenobamate	115	3,812	$184,585
Fycompa	Perampanel	78	4,191	$151,499
Fintepla	Fenfluramine Hcl	11	330	$106,752
Nayzilam	Midazolam	51	849	$61,325

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	186	$116,178	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,021	LivaNova USA, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Micheal Patrick Macken, MD?

Tedicare shows public-source Medicare data for Micheal Patrick Macken, MD (NPI 1336110550), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Micheal Patrick Macken, MD have ACO affiliation data?

Micheal Patrick Macken, MD is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620) and Northwestern Medicine Health Network ACO LLC (MSSP, ACO ID A5444).

What billing organization is linked to Micheal Patrick Macken, MD?

Micheal Patrick Macken, MD is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Micheal Patrick Macken, MD have Open Payments data?

Micheal Patrick Macken, MD has 187 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.